Your institution may have access to this item. Find your institution then sign in to continue.
Title
Gene therapy should welcome public scrutiny.
Abstract
Editorial. Focuses on the importance of allaying public anxieties concerning risks n the field of gene therapy. Regulatory agencies that should provide clear guidelines for the disclosure of adverse events in clinical trials; Disadvantages caused by public scrutiny to research and commercial development of technology; Positive aspects of public scrutiny.